Skip to content

Clinical trials

Phase 1/2 Neoplasms by Site trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Phase: Phase 1/2 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20113
20131
20141
20151
20174
20182
20195
20221
20234
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting9
Terminated4
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Bristol-Myers Squibb2
Revolution Medicines, Inc.2
AVEO Pharmaceuticals, Inc.1
Advanced Accelerator Applications1
Arno Therapeutics1
Atara Biotherapeutics1
BBB-Therapeutics B.V.1
BeiGene USA, Inc.1
Cerenome1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site27
Neoplasms25
Lung Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Head and Neck Neoplasms9
Gastrointestinal Neoplasms8
Carcinoma7
Central Nervous System Neoplasms7
Colorectal Neoplasms7
Lung Diseases7

Trials

Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.